Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim November 1, 2017 AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal December 28, 2017 Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017
Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017